108 related articles for article (PubMed ID: 22187892)
1. [Switching to monotherapy and optimization of drug therapy for long-term hospitalized patients and chronically sick patients].
Hirao T
Seishin Shinkeigaku Zasshi; 2011; 113(10):1041-7. PubMed ID: 22187892
[TBL] [Abstract][Full Text] [Related]
2. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
3. [Is it valid to concurrently use multiple antipsychotics for patients with schizophrenia?].
Suzuki T; Watanabe K; Yagi G; Kashima H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Aug; 25(4):159-68. PubMed ID: 16190364
[TBL] [Abstract][Full Text] [Related]
4. Prescription profiles for pharmacological treatment of Japanese inpatients with schizophrenia: comparison between 2007 and 2009.
Yoshio T; Inada T; Uno J; Miwa T; Kitagawa K; Miyahara Y; Umeda K; Kato T; Inagaki A; Nabeshima T
Hum Psychopharmacol; 2012 Jan; 27(1):70-5. PubMed ID: 22249957
[TBL] [Abstract][Full Text] [Related]
5. A clinical case series of switching from antipsychotic polypharmacy to monotherapy with a second-generation agent on patients with chronic schizophrenia.
Suzuki T; Uchida H; Watanabe K; Yagi G; Kashima H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):361-9. PubMed ID: 14751434
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of antipsychotic monotherapy vs. polypharmacy in schizophrenia: to switch or to combine? A nationwide study in Hungary.
Katona L; Czobor P; Bitter I
Schizophr Res; 2014 Jan; 152(1):246-54. PubMed ID: 24275583
[TBL] [Abstract][Full Text] [Related]
7. [The trend for megadose polypharmacy in antipsychotic pharmacotherapy: a prescription survey conducted by the psychiatric clinical pharmacy research group].
Yoshio T
Seishin Shinkeigaku Zasshi; 2012; 114(6):690-5. PubMed ID: 22844820
[TBL] [Abstract][Full Text] [Related]
8. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
[TBL] [Abstract][Full Text] [Related]
9. Monotherapy versus polypharmacy for hospitalized psychiatric patients.
Strous RD; Lerner V
Am J Psychiatry; 2005 Mar; 162(3):631-2; author reply 632-3. PubMed ID: 15741496
[No Abstract] [Full Text] [Related]
10. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
11. [Basis of prescribing antipsychotics].
Sato S
Seishin Shinkeigaku Zasshi; 2011; 113(10):1036-40. PubMed ID: 22187891
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
13. [Polypharmacy in the treatment of schizophrenia].
Messer T; Tiltscher C; Schmauss M
Fortschr Neurol Psychiatr; 2006 Jul; 74(7):377-91. PubMed ID: 16804806
[TBL] [Abstract][Full Text] [Related]
14. A study of polypharmacy with second generation antipsychotics in patients with severe and persistent mental illness.
Megna JL; Kunwar AR; Mahlotra K; Sauro MD; Devitt PJ; Rashid A
J Psychiatr Pract; 2007 Mar; 13(2):129-37. PubMed ID: 17414692
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with amisulpride in patients with schizophrenia discharged from a short-term hospitalization unit: a 1-year retrospective study.
Molina JD; Lerma-Carrillo I; Leonor M; Pascual F; Blasco-Fontecilla H; González-Parra S; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2009; 32(1):10-5. PubMed ID: 18978498
[TBL] [Abstract][Full Text] [Related]
16. Polypharmacy with second-generation antipsychotics: a review of evidence.
Pandurangi AK; Dalkilic A
J Psychiatr Pract; 2008 Nov; 14(6):345-67. PubMed ID: 19057237
[TBL] [Abstract][Full Text] [Related]
17. A prospective survey on drug choice for prescriptions for admitted patients with schizophrenia.
Ito C; Kubota Y; Sato M
Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S35-40. PubMed ID: 10560896
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic polypharmacy in patients with schizophrenia in a brief hospitalization unit.
Lerma-Carrillo I; de Pablo Brühlmann S; del Pozo ML; Pascual-Pinazo F; Molina JD; Baca-García E
Clin Neuropharmacol; 2008; 31(6):319-32. PubMed ID: 19050409
[TBL] [Abstract][Full Text] [Related]
19. Prescribing for inpatients with schizophrenia: an international multi-center comparative study.
Bitter I; Chou JC; Ungvari GS; Tang WK; Xiang Z; Iwanami A; Gaszner P
Pharmacopsychiatry; 2003 Jul; 36(4):143-9. PubMed ID: 12905100
[TBL] [Abstract][Full Text] [Related]
20. [Measures to reduce high-dose multiple antipsychotics in Japan].
Sukegawa T
Seishin Shinkeigaku Zasshi; 2012; 114(6):696-701. PubMed ID: 22844821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
